Manual Therapy Dosage Factorial Study

Sponsor
McMaster University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00560807
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), National Institutes of Health (NIH) (NIH), University of Western Ontario, Canada (Other)
0
1
12

Study Details

Study Description

Brief Summary

This study will determine biological responses to different dosages of neck mobilization intervention in patients, providing opportunities to identify the optimal dosage, predictors of response, outcome measures as well as the longitudinal changes in biology.

Subjects with acute whiplash associated disorders (WAD) II and III with a symptom duration of less than 30 days (acute) or 30 to 90 days (subacute) will be randomly assigned to receive different doses of mobilization. The dosage treatment groups will differ in the number of sessions (1, 2 or 3 times per week) and the duration of treatment (duration of treatment intervention will be 3, 6, or 12 weeks). A zero treatment/week option is included to insure that the impact of any mobilization is included and because previous studies suggest a single mobilization may have a treatment effect.

All patient participants will receive a core standard treatment of education, advice to stay active, and neck/postural stretching and strengthening exercise. All patient participants will receive supervised exercise and advice for the full 12 weeks. All patients will be provided with an instructional CD and exercise brochure to reinforce the whole program.

Follow-up assessments will consist of quantitative sensory testing (vibration threshold; current perception threshold), the Neck Walk Index (NWI), the Upper Cyclical Reach and Grasp Task, muscle biology analyses (cytokine analyses), central breathing control tests (capnography), range of motion, head flexion endurance, and self-report symptoms and disability (Visual Analogue Scale; Neck Disability Index; Disabilities of the Arm, Shoulder, Hand; pain threshold and tolerance algometry; and perceived self-efficacy; SF-36).

Hypothesis: During recovery, patient are expected to transition from an acute painful state to one where they can resume normal activity and add intensive strengthening exercises.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mobilization
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Manual Therapy Dosage Factorial Study

Arms and Interventions

Arm Intervention/Treatment
No Intervention: A

Zero treatment/3 weeks

Active Comparator: B

Frequency of Mobilization:1/week Duration of Mobilization Treatment: 3 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: C

Frequency of Mobilization: 1/week Duration of Mobilization Treatment: 6 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: D

Frequency of Mobilization: 1/week Duration of Mobilization Treatment: 12 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: F

Frequency of Mobilization: 2/week Duration of Mobilization Treatment: 3 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: G

Frequency of Mobilization: 2/week Duration of Mobilization Treatment:6 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: H

Frequency of Mobilization: 2/week Duration of Mobilization Treatment: 12 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: J

Frequency of Mobilization: 3/week Duration of Mobilization Treatment: 3 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: K

Frequency of Mobilization: 3/week Duration of Mobilization Treatment:6 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

Active Comparator: L

Frequency of Mobilization: 3/week Duration of Mobilization Treatment:12 weeks

Procedure: Mobilization
Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.

No Intervention: E

Zero treatment/6 weeks

No Intervention: I

Zero treatment/12 weeks

Outcome Measures

Primary Outcome Measures

  1. Quantitative Sensory Testing (QST) [Within 24 weeks]

  2. Current Perception Threshold (CPT) [Within 24 weeks]

  3. Neck Walk Index (NWI) [Within 24 weeks]

  4. Cyclical Reach and Grasp Test (CRGT) [Within 24 weeks]

  5. Muscle Biology (cytokine analyses) [Within 24 weeks]

  6. Central Breathing Control Test [Within 24 weeks]

  7. Neck Disability Index [Within 24 weeks]

  8. Pain Intensity - Visual Analogue Scale (VAS) [Within 24 weeks]

Secondary Outcome Measures

  1. Global Perceived Effect (GPE) [Within 24 weeks]

  2. Disabilities of the Arm, Shoulder, and Hand (DASH) [Within 24 weeks]

  3. Pain Threshold and Pain Tolerance Algometry [Within 24 weeks]

  4. Head Flexion Endurance [Within 24 weeks]

  5. Range of Motion [Within 24 weeks]

  6. Quality of Life (SF-36v2) [within 24 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days or subacute (30 to 90 days)

  • pain in the neck but may radiate to the shoulder region or upper extremities or have an associated headache

  • pain intensity must be at or above 30 mm on a 100 mm visual analogue scale

  • must be a new episode of pain with ,no other occurrences of neck pain requiring treatment in the previous 4 months.

Exclusion Criteria:
  • arthritis, neurological diseases, fractures, dislocation, rheumatoid arthritis, long tract signs and malignancy

  • conditions that make the provision of neck exercise unsafe

Contacts and Locations

Locations

Site City State Country Postal Code
1 McMaster University Hamilton Ontario Canada L8S 1C7

Sponsors and Collaborators

  • McMaster University
  • Canadian Institutes of Health Research (CIHR)
  • National Institutes of Health (NIH)
  • University of Western Ontario, Canada

Investigators

  • Principal Investigator: Joy C MacDermid, PhD, McMaster University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00560807
Other Study ID Numbers:
  • 1 R21 AT004263
First Posted:
Nov 20, 2007
Last Update Posted:
Sep 23, 2015
Last Verified:
Sep 1, 2015

Study Results

No Results Posted as of Sep 23, 2015